DELCATH RECEIVES REGULATORY APPROVAL FOR THE GENERATION TWO HEPATIC CHEMOSAT® DELIVERY SYSTEM IN AUSTRALIA

[at noodls] – DELCATH RECEIVES REGULATORY APPROVAL FOR THE GENERATION TWO HEPATIC CHEMOSAT® DELIVERY SYSTEM IN AUSTRALIA NEW YORK, NY – November 5, 2012 – Delcath Systems, Inc. (NASDAQ: DCTH) today announced the Therapeutic … more

View todays social media effects on DCTH

View the latest stocks trending across Twitter. Click to view dashboard